,address1,address2,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Dr. George  Adams B.A.Sc., ICD.D., M.A.Sc., Ph.D.', 'age': 70, 'title': 'Exec. Chairman', 'yearBorn': 1952, 'fiscalYear': 2021, 'totalPay': 177265, 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
1,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Dr. Alvira  Macanovic Ph.D.', 'title': 'CEO, Pres and VP of Operations, Regulatory Affairs & Quality Assurance', 'fiscalYear': 2021, 'totalPay': 182189, 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
2,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Mr. Victor  Hugo C.M.A., CPA', 'age': 52, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2021, 'totalPay': 65786, 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
3,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Mr. Hirotaka  Katagiri', 'title': 'CTO &  Bus. Devel. Division Director', 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
4,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Ms. Jessica  Naman', 'title': 'Director of Marketing', 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
5,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Mr. Desmond  Hirson', 'title': 'Consultant', 'fiscalYear': 2019, 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
6,18 Hook Avenue,Unit 101,Toronto,ON,M6P 1T4,Canada,416-848-4156,https://www.ventripoint.com,Medical Devices,Healthcare,"Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity of chemotherapy treatments for cancer, and Covid-19 related heart issues. The company was incorporated in 2005 and is headquartered in Toronto, Canada.","{'maxAge': 1, 'name': 'Mr. Jim  Graba', 'title': 'Application Specialist & Chief Trainer', 'exercisedValue': 0, 'unexercisedValue': 0}",1640908800,86400,4,0.165,0.1566,0.1536,0.1599,0.165,0.1566,0.1536,0.1599,0.0,0.282784,3492,3492,49022,61395,61395,0.0,0.0,0,0,24366210,0.0918,0.255,474.53085,0.2031558,0.17590925,0.0,0.0,USD,21454738,0.0,154079487,156824000,0.0175,0.0,0.015,10.34,1672444800,1703980800,1688083200,-4969554,-0.02,1:10,1449446400,417.83,-4.258,PNK,EQUITY,VPTDF,VPTDF,VENTRIPOINT DIAGNOSTICS LTD,VentriPoint Diagnostics Ltd.,1285162200,America/New_York,EDT,-14400000,0.1551,none,3310100,0.021,-5038146,441451,3.034,3.093,51348,18.472,0.0,-0.54662,-1.13242,-2403811,-3972674,0.87328005,0.0,-98.279305,CAD,
